NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01839773,Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer,https://clinicaltrials.gov/study/NCT01839773,DREAM,COMPLETED,The objective of this study is to evaluate the efficacy and safety of DHP107 (Oral paclitaxel) in comparison to Taxol®(IV paclitaxel) in Patients With Metastatic or Recurrent Gastric Cancer After Failure of 1st Line Chemotherapy With Fluoropyrimidine +/- Platinum.,NO,Stage IV Gastric Cancer,DRUG: Paclitaxel|DRUG: Paclitaxel,"Progression Free Survival, PFS is defined as the time From date of randomization until the date of first documented progression or death, assessed up to 24 months., Participants will be followed until progression, an expected average of 4 months.","Overall Survival, OS is defined as the time from the date of inclusion to the date of death, regardless of the cause of death., Until 6 months after the last participant is enrolled, assessed up to 24 months.|Overall Response Rate, ORR is defined by Response Evaluation Criteria in Solid Tumors (RECIST) (v.1.1) criteria., Participants will be followed every 6 weeks until progression, an expected average of 4 months.",,"Daehwa Pharmaceutical Co., Ltd.",,ALL,"ADULT, OLDER_ADULT",PHASE3,238,INDUSTRY,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,107CS-3,2013-03,2015-08,2015-08,2013-04-25,,2024-07-25,"Inje University Haeundae Paik Hospital, Busan, 612-896, Korea, Republic of|Chonnam National University Hwasun Hospital, Chungnam, 519-763, Korea, Republic of|Kyungpook National University Medical Center, Daegu, 702-210, Korea, Republic of|National Cancer Center, Goyang-si, 410-769, Korea, Republic of|Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of|Yonsei University Severance Hospital, Seoul, 120-752, Korea, Republic of|Samsung Medical Center, Seoul, 135-710, Korea, Republic of|Yonsei University Gangnam Severance Hospital, Seoul, 135-720, Korea, Republic of|Seoul St. Mary's Hospital, Seoul, 137-701, Korea, Republic of|Asan Medical Center, University of Ulsan College of Medicine, Seoul, 138-736, Korea, Republic of|Asan Medical Center, Seoul, 138-736, Korea, Republic of|Korea University Guro Hospital, Seoul, 152-703, Korea, Republic of|Ajou University Hospital, Suwon, 443-380, Korea, Republic of",
